Article Details

Biogen proposes to buy remaining stake in Sage in $442 million deal - TradingView

Retrieved on: 2025-01-11 01:32:34

Tags for this article:

Click the tags to see associated articles and topics

Biogen proposes to buy remaining stake in Sage in $442 million deal - TradingView. View article details on hiswai:

Excerpt

In July, Sage also scrapped the development of another neurological disorder drug it was developing with Biogen. ... Mobile app · CME Group futures ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo